sitemap.xml - Search
About 7 results
Open links in new tab
    Kizdar net | Kizdar net | Кыздар Нет
  1. Global web icon
    veeva.com
    https://ctv.veeva.com › study › an-open-label-study-to-assess-the-safety...

    An Open-label Study to Assess the Safety, Efficacy, and Cellular ...

    Sep 7, 2026 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  2. Global web icon
    ichgcp.net
    https://ichgcp.net › clinical-trials-registry

    An Open-label Study to Assess the Safety, Efficacy, and Cellular ...

    Sep 26, 2024 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  3. Global web icon
    centerwatch.com
    https://www.centerwatch.com › clinical-trials › listings › an-open-label-study...

    An Open-label Study to Assess the Safety, Efficacy, and Cellular ...

    May 27, 2026 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  4. Global web icon
    eichor.com
    https://eichor.com › study

    An Open-label Study to Assess the Safety… (NCT06617793)

    3 days ago · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of YTB323 …

  5. Global web icon
    medpath.com
    https://trial.medpath.com › clinical-trial

    An Open-label Study to Assess the Safety,... | Clinical Trial

    Feb 24, 2025 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  6. Global web icon
    novartis.com
    https://www.novartis.com › node › printable › print

    An Open-label Study to Assess the Safety, Efficacy, and Cellular ...

    This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of YTB323 in …

  7. Global web icon
    ichgcp.net
    https://ichgcp.net › clinical-trials-registry

    Phase 1/2 Study of YTB323 CAR-T Therapy for Relapsing Multiple Sclerosis

    Novartis-sponsored Phase 1/2 trial investigating YTB323 CAR-T cell therapy for relapsing multiple sclerosis patients with …

  8. Global web icon
    clinicaltrialsfinder.org
    https://www.clinicaltrialsfinder.org › trials

    An Open-label Study to Assess the Safety, Efficacy, and Cellular ...

    Feb 24, 2025 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  9. Global web icon
    springer.com
    https://adisinsight.springer.com › trials

    An Open-label, Multi-center, Phase 1/2 Study to Assess Safety, Efficacy ...

    Sep 4, 2026 · This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of …

  10. Global web icon
    whichtrial.com
    https://whichtrial.com › trial

    An Open-label Study to Assess the Safety… | NCT06617793

    This is an open-label, multi-center, non-confirmatory study to assess the safety, efficacy, and cellular kinetics of YTB323 in …